We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Overdose deaths linked to synthetic benzodiazepines rose more than sixfold between 2019 and 2020, according to a new report from the Centers for Disease Control and Prevention.
A federal judge has ruled that OxyContin maker Purdue Pharma will be dissolved under a settlement deal that resolves all civil litigation against the family that owns the company, CNN reports.
Organizations that provide the opioid overdose antidote naloxone at an affordable price are reporting shortages of the medicine, The Washington Post reports.
Guidelines released by the Centers for Disease Control and Prevention in 2016 aimed at making opioid prescribing safer may have led to shorter prescriptions with lower doses, a new study suggests.
A new study finds more than half of U.S. adults age 65 and older who use alcohol and visited their health care provider in the past year were not asked about their alcohol use.
Policymakers should heed lessons learned from tobacco control efforts when legalizing marijuana in order to protect youth, according to a commentary in the Journal of Adolescent Health.
View our curated digest of the latest research news, including an evidence-based parenting intervention designed for mothers struggling with addiction.
Children who use e-cigarettes are up to three times more likely to use tobacco products in the future, according to a new report by the World Health Organization.
Addiction treatment advocates have concerns about the $26 billion settlement announced last week that ended lawsuits over the opioid crisis, Reuters reports. Advocates say the funds will arrive slowly and could be misspent.
Hospitals that fail to provide necessary care for substance use disorders in the Emergency Department can face legal liability under federal law, according to a new report.
A new study suggests the proportion of cases of schizophrenia associated with cannabis use disorder has increased three- to four-fold during the past two decades.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
